10 completed, 1 recruiting, 1 terminated, 1 unknown. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 10, Recruiting 1, Terminated 1, Unknown 1 |
Follow Psychological Well-Being: new trials by email Literature Review of Psychological Well-Being trials Research Report on Psychological Well-Being
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Esketamine With or Without Integration Therapy for Treatment-Resistant Depression Esketamine hydrochloride (intranasal), Integration Therapy - Treatment-resistant Depression (TRD) | Phase 4 | Recruiting | University of Puerto Rico | 20 | 2026-02-01 | 2026-01-27 |
| The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment Cannabidiol Oil, Homotaurine - Mild Cognitive Impairment | Phase 4 | Unknown | Aristotle University Of Thessaloniki | 90 | 2021-04-01 | 2021-08-26 |
| A Retrospective Effectiveness Trial of Ketamine-Assisted Psychotherapy in Adult Patients Coping With Mental Health Ketamine-Assisted Psychotherapy (KAP) - Depression, Anxiety | Phase 4 | Completed | Field Trip Health | 1806 | 2020-03-13 | 2024-03-20 |
| Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression Escitalopram, Bupropion - Depression | Phase 4 | Terminated | University of Texas Southwestern Medical Center | 18 | 2019-07-23 | 2023-04-18 |
| Optimum Thiamine Intervention (OpTIn) Trial Thiamine Hydrochloride - Wernicke-Korsakoff Syndrome | Phase 4 | Completed | Menzies School of Health Research | 334 | 2014-09-01 | 2019-08-16 |
| The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff Vitamin D3, Placebo - Seasonal Affective Disorder, Vitamin D3 | Phase 4 | Completed | Connie Thuree Nielsen, consultant, MD, ph.d | 50 | 2011-10-01 | 2012-03-29 |
| Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression Selegiline Transdermal System, Placebo - Major Depressive Disorder | Phase 4 | Completed | Somerset Pharmaceuticals | 308 | 2007-07-01 | 2014-01-15 |
| Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults donepezil, Placebo (cornstarch) - Mental Health, Geriatrics | Phase 4 | Completed | Sunnybrook Health Sciences Centre | 22 | 2007-06-01 | 2019-05-10 |
| Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue. Provigil - Major Depression, Mental Health | Phase 4 | Completed | Emory University | 100 | 2003-02-01 | 2013-11-11 |
| Effectiveness of Screening and Counselling for Elderly With Psychological Problems Brief counselling, Behavior - Mental Illness | Phase 4 | Completed | The University of Hong Kong | 450 | 2002-11-01 | 2006-01-27 |
| Study To Evaluate The Effects Of Gabitrilâ„¢ In Patients With Social Anxiety Disorder Gabitril - Social Anxiety Disorder | Phase 4 | Completed | Emory University | 50 | 2002-06-01 | 2013-11-11 |
| Psychological Well-being, Recovery and Sexuality After Total and Subtotal Hysterectomy Total abdominal hysterectomy, Subtotal abdominal hysterectomy - Hysterectomy | Phase 4 | Completed | University Hospital, Linkoeping | 200 | 1998-03-01 | 2012-06-11 |
| Thyroid Medication and Antidepressants for Treating Major Depression Triiodothyronine, Placebo, Sertraline - Major Depression | Phase 4 | Completed | Emory University | 153 | 1996-09-01 | 2015-11-17 |
Depression (6) · Depressive Disorder, Major (4) · Anxiety Disorders (1) · Cognitive Dysfunction (1) · Depressive Disorder, Treatment-Resistant (1) · Dissociative Disorders (1) · Korsakoff Syndrome (1) · Mental Disorders (1) · Mood Disorders (1) · Neurologic Manifestations (1) · Phobia, Social (1) · Seasonal Affective Disorder (1) · Stress Disorders, Post-Traumatic (1)
Behavior (13) · Personal Satisfaction (13) · Mental Disorders (9) · Behavioral Symptoms (6) · Depressive Disorder (6) · Mood Disorders (5) · Anxiety Disorders (1) · Cognition Disorders (1) · Memory Disorders (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurocognitive Disorders (1) · Pathological Conditions, Signs and Symptoms (1) · Phobic Disorders (1) · Signs and Symptoms (1)
5''-hydroxycannabidiol glucoside (1) · Bupropion (1) · Cannabidiol (1) · Cholecalciferol (1) · Donepezil (1) · Escitalopram (1) · Esketamine (1) · Exercise (1) · Modafinil (1) · Selegiline (1) · Sertraline (1) · Starch (1) · Thiamine (1) · Tiagabine (1) · Triiodothyronine (1)
Emory University (3) · Aristotle University Of Thessaloniki (1) · Connie Thuree Nielsen, consultant, MD, ph.d (1) · Field Trip Health (1) · Menzies School of Health Research (1) · Somerset Pharmaceuticals (1) · Sunnybrook Health Sciences Centre (1) · The University of Hong Kong (1) · University Hospital, Linkoeping (1) · University of Puerto Rico (1) · University of Texas Southwestern Medical Center (1)
United States (6) · Canada (2) · Australia (1) · Denmark (1) · Greece (1) · Puerto Rico (1) · Sweden (1)
Philip T Ninan, MD (2) · Boadie W Dunlop, MD, MS (1) · Chris Lo, PhD (1) · Cindy L Lam, MD (1) · Karen G Gonzalez-Martinez, MD, MSc (1) · Krista Lanctot, PhD (1) · Kylie Dingwall, PhD (1) · Madhukar H Trivedi, MD (1) · Mark Rapoport, MD, FRCPC (1) · Melissa L Goodhead (1) · Michel Bedard, PhD (1) · Nathan Herrmann, MD, FRCPC (1) · Ryan Yermus, MD (1)
PMID 22964160, PMID 25125215, PMID 41938228
R01MH056946 (1)